Uwell Biopharma, Inc. (7902)
Market Closed
13 Aug, 05:30
TWSE TWSE Primary NT$
34. 75
+0.6
+1.757%
NT$
- Market Cap
- P/E Ratio
- Div Yield
21,999 Volume
- Eps
NT$ 34.15
Previous Close Want to track 7902 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Uwell Biopharma, Inc. (7902) Statistics
Valuation metrics
Market Cap -
Enterprise value 6.35B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 20.01
Enterprise Value/Revenue 181,543.42
Enterprise Value/EBITDA -97.54
Overview
Shares outstanding -
Float 78.07M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 105.81K
Average volume (90 days) 157.06K
Price summary
52-Week low 21
52-Week high 51.5
Beta -
50-Day moving average 35.24
200-Day moving average 38.06
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -945.6%
Operational effectiveness
Return on assets -0.2%
Return on equity -0.33%
Income Statement
Revenue (ttm) 35K
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -0.92%
Gross profit (ttm) 28K
EBITDA -65.14M
Net income to common (ttm) -66.2M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 320.24M
Total cash per share (mrq) 1.6
Total debt (mrq) 4.26M
Total Debt/Equity (mrq) 1.27
Current ratio (mrq) 24.61%
Book value per share (mrq) 1.67
Cash Flow
Cash flow statement -52.31M
Levered free cash flow (LFCF) -29.27M
